SCHEMBL6979181

SCHEMBL6979181

Cc1ccc(S(=O)(=O)OCC2COc3ccc(Br)cc3O2)cc1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CA2 P00918 3/20 0.47
ALDH1A1 P00352 2/20 0.47
CYP3A4 P08684 2/20 0.47
CYP2D6 P10635 2/20 0.47
TSHR P16473 2/20 0.47
MAPT P10636 2/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
MAPK1 P28482 1/20 0.47
LMNA P02545 2/20 0.46
FFAR1 O14842 6/20 0.45
SMN1; SMN2 Q16637 1/20 0.44
HTR6 P50406 1/20 0.42
PYGL P06737 1/20 0.40
RAB9A P51151 1/20 0.39
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1883283 1.00 CA2 (0.47) CA2ALDH1A1CYP3A4CYP2D6TSHR
SCHEMBL17282519 0.93 CA2 (0.53) CA2ALDH1A1CYP3A4CYP2D6TSHR
SCHEMBL6973472 0.90 CA2 (0.57) CA2ALDH1A1CYP3A4CYP2D6TSHR
SCHEMBL6973466 0.90 CA2 (0.57) CA2ALDH1A1CYP3A4CYP2D6TSHR
SCHEMBL1019038 0.87 FFAR1 (0.49) CA2ALDH1A1CYP3A4CYP2D6TSHR
SCHEMBL1018787 0.87 FFAR1 (0.49) CA2ALDH1A1CYP3A4CYP2D6TSHR
SCHEMBL1019975 0.87 FFAR1 (0.49) CA2ALDH1A1CYP3A4CYP2D6TSHR
SCHEMBL11102654 0.87 LMNA (0.48) CA2ALDH1A1CYP3A4CYP2D6TSHR
SCHEMBL1044755 0.86 CA2 (0.53) CA2CYP2C9LMNAFFAR1SMN1; SMN2
SCHEMBL1872709 0.86 CA2 (0.47) CA2ALDH1A1CYP3A4CYP2D6TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0839145-B1 HETEROCYCLYLCARBOXAMIDE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS ABBOTT GMBH & CO KG (DE) 2003-11-05 EP disclosed
US-6136825-A ANTIDEPRESSANTS AND CENTRAL NERVOUS SYSTEM AGENTS KNOLL AKTIENGESELLSCHAFT 2000-10-24 US disclosed
US-5935973-A AFFINITY FOR 5-HT1A, ALPHA1, ALPHA2 AND/OR D2 RECEPTORS; ANTIDEPRESSANTS, ANXIOLYTIC AGENTS, PSYCHOSES, DYSKINESIAS, PARKINSON'S DISEASE, HYPOTENSIVE AGENTS, TOURETTE'S SYNDROME, OBSESSIVE-COMPULSIVE BEHAVIOUR, PANIC ATTACKS, SOCIAL PHOBIAS KNOLL AKTIENGESELLSCHAFT (DE) 1999-08-10 US disclosed
EP-0839145-A1 HETEROCYCLYLCARBOXAMIDE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS Knoll AG (DE) 1998-05-06 EP disclosed
WO-1997003071-A1 HETEROCYCLYLCARBOXAMIDE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS KNOLL AKTIENGESELLSCHAFT (DE) 1997-01-30 WO disclosed